Your session is about to expire
← Back to Search
High-Dose Requip for Parkinson's Disease
Study Summary
This trial is testing if Requip, a drug used to treat Parkinson's, is more effective at a higher dose than what is currently FDA approved.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I am taking the highest dose of my Parkinson's medication.My medication doses have not changed in the last 4 weeks.I am 25 years old or older.I experience significant swelling.I am experiencing hallucinations.I am not pregnant and agree to use birth control during the study.I am currently pregnant or breastfeeding.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the screening requirements for this particular medical experiment?
"20 individuals, aged 25 or older and currently suffering from parkinson disease, are being enrolled in this clinical trial. However, it is essential that these patients also meet the following age criterion: greater than or equal to 25 years old."
We are interested in patients who fall within the 20-year age bracket - does this study apply to them?
"To be applicable for this particular study, patients must between the ages of 25 and 50. Out of 514 total clinical trials, 28 are specifically geared towards minors while the remaining 486 are for senior citizens."
Has this medication been cleared by the FDA?
"This clinical trial is in Phase 3, which suggests that while there is evidence of the treatment's efficacy, multiple rounds of data support its safety. Consequently, our team rates this treatment as a 3 on our scale."
Are new patients currently being enrolled in this clinical trial?
"According to the information on clinicaltrials.gov, this trial is not currently looking for patients. This study was first posted on November 1st 2005 and last updated February 2nd 2006. Although this particular trial isn't searching for candidates, there are 517 other ongoing studies that are actively recruiting patients right now."
Share this study with friends
Copy Link
Messenger